Application of thrombelastography/thromboelastometry to veterinary medicine

Veterinary Clinical Pathology

Volumn 39, Issue 4, 2010, Pages 405-416

  Kol, Amir ^a   Borjesson, Dori L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coagulation; Hemostasis; Hypercoagulability; Hypocoagulability; TEG

Indexed keywords

ANTICOAGULANT AGENT;

ANIMAL; ANIMAL DISEASE; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD VISCOSITY; INSTRUMENTATION; MONITORING; PHYSIOLOGY; REVIEW; THROMBOCYTE; THROMBOELASTOGRAPHY;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; BLOOD PLATELETS; BLOOD VISCOSITY; MONITORING, PHYSIOLOGIC; THROMBELASTOGRAPHY;

ANIMALIA; CANIS FAMILIARIS; EQUIDAE;

EID: 78649843807     PISSN: 02756382     EISSN: 1939165X     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2010.00263.x     Document Type: Review

References (106)

1. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie; einem neuen Untersuchungs verfahren [Coagulation analysis with thrombelastography, a new method]. Klin Wochenschr. 1948;26:577-583.
2. Hartert H. Die thrombelastographie. Eine methode zur physikalischen analyse des blutgerinnungsvarganges [Thrombelastography, a method for physical analysis of blood coagulation]. Z Gesamte Exp Med. 1951;117:189-203.
3. Hoffman M, Monroe DM III. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958-965.
4. Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005;45:1413-1425.
5. Nelson OL, Andreasen C. The utility of plasma D-dimer to identify thromboembolic disease in dogs. J Vet Intern Med. 2003;17:830-834.
6. ROTEM Marketing Approval by FDA. Available at: Accessed July 27, 2010.
7. Jackson GN, Ashpole KJ, Yentis SM. The TEG vs the ROTEM thromboelastography/thromboelastometry systems. Anaesthesia. 2009;64:212-215.
8. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol. 2005;27:81-90.
9. Kang YG, Martin DJ, Marquez J, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg. 1985;64:888-896.
10. Spiess BD, Gillies BS, Chandler W, et al. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth. 1995;9:168-173.
11. Kraft W. Das thrombelastogramm der gesunden hauskatze und die behandlung der verbrauchskoagulopathie bei panleukopenie [Thrombelastogram in healthy domestic cats and therapy of disseminated intravascular coagulation (DIC) in panleukopenia]. Berl Munch Tierarztl Wochenschr. 1973;86:394-396.
12. Bauer N, Eralp O, Moritz A. Establishment of reference intervals for kaolin-activated thromboelastography in dogs including an assessment of the effects of sex and anticoagulant use. J Vet Diagn Invest. 2009;21:641-648.
13. Epstein KL, Brainard BM, Lopes MA, et al. Thrombelastography in 26 healthy horses with and without activation by recombinant human tissue factor. J Vet Emerg Crit Care (San Antonio). 2009;19:96-101.
14. Leclere M, Lavoie JP, Dunn M, Bédard C. Evaluation of a modified thrombelastography assay initiated with recombinant human tissue factor in clinically healthy horses. Vet Clin Pathol. 2009;38:462-466.
15. Marschner CB, Bjornvad CR, Kristensen AT, et al. Thromboelastography results on citrated whole blood from clinically healthy cats depend on modes of activation. Acta Vet Scand. 2010;52:38-42.
16. Paltrinieri S, Meazza C, Giordano A, Tunesi C. Validation of thromboelastometry in horses. Vet Clin Pathol. 2008;37:277-285.
17. Wiinberg B, Jensen AL, Rojkjaer R, Johansson P, Kjelgaard-Hansen M, Kristensen AT. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol. 2005;34:389-393.
18. Kashuk JL, Moore EE, Sabel A, et al. Rapid thromboelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery. 2009;146:764-772; discussion 772-764.
19. Alwood AJ, Downend AB, Brooks MB, et al. Anticoagulant effects of low-molecular-weight heparins in healthy cats. J Vet Intern Med. 2007;21:378-387.
20. Zuckerman L, Cohen E, Vagher JP, Woodward E, Caprini JA. Comparison of thrombelastography with common coagulation tests. Thromb Haemost. 1981;46:752-756.
21. Pittman JR, Koenig A, Brainard BM. The effect of unfractionated heparin on thrombelastographic analysis in healthy dogs. J Vet Emerg Crit Care (San Antonio). 2010;20:216-223.
22. Bowbrick VA, Mikhailidis DP, Stansby G. Influence of platelet count and activity on thromboelastography parameters. Platelets. 2003;14:219-224.
23. Wiinberg B, Jensen AL, Rozanski E, et al. Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs. Vet J. 2009;179:121-129.
24. Alexander DC, Butt WW, Best JD, Donath SM, Monagle PT, Shekerdemian LS. Correlation of thromboelastography with standard tests of anticoagulation in paediatric patients receiving extracorporeal life support. Thromb Res. 2010;125:387-392.
25. Park MS, Martini WZ, Dubick MA, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma. 2009;67:266-275; discussion 275-266.
26. Wagg CR, Boysen SR, Bedard C. Thrombelastography in dogs admitted to an intensive care unit. Vet Clin Pathol. 2009;38:453-461.
27. Akay OM, Ustuner Z, Canturk Z, Mutlu FS, Gulbas Z. Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography. Med Oncol. 2009;26:358-364.
28. Lang T, Johanning K, Metzler H, et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg. 2009;108:751-758.
29. Wiinberg B, Jensen AL, Johansson PI, Rozanski E, Tranholm M, Kristensen AT. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med. 2008;22:357-365.
30. Chan MY, Andreotti F, Becker RC. Hypercoagulable states in cardiovascular disease. Circulation. 2008;118:2286-2297.
31. Vaya A, Mira Y, Martinez M, et al. Biological risk factors for deep vein thrombosis. Clin Hemorheol Microcirc. 2002;26:41-53.
32. Vannucchi AM, Barbui T. Thrombocytosis and thrombosis. Hematology Am Soc Hematol Educ Program. 2007;363-370.
33. Kuo YR, Yang KD, Huang MN, Wei FC, Jeng SF. Reactive thrombocytosis without endothelial damage does not affect the microvascular anastomotic patency. Ann Plast Surg. 2003;50:57-63.
34. Levrat A, Gros A, Rugeri L, et al. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth. 2008;100:792-797.
35. Schochl H, Frietsch T, Pavelka M, Jambor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma. 2009;67:125-131.
36. Summaria L, Sandesara J, Yang G, Vagher JP, Caprini JA. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses. Thromb Haemost. 1986;56:71-79.
37. Sivula M, Pettila V, Niemi TT, Varpula M, Kuitunen AH. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagul Fibrinolysis. 2009;20:419-426.
38. Theusinger OM, Nurnberg J, Asmis LM, Seifert B, Spahn DR. Rotation thromboelastometry (ROTEM) stability and reproducibility over time. Eur J Cardiothorac Surg. 2010;37:677-683.
39. White H, Zollinger C, Jones M, Bird R. Can thromboelastography performed on kaolin-activated citrated samples from critically ill patients provide stable and consistent parameters? Int J Lab Hematol. 2010;32:167-173.
40. Johansson PI, Bochsen L, Andersen S, Viuff D. Investigation of the effect of kaolin and tissue-factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography. Transfusion. 2008;48:2377-2383.
41. Wiinberg B, Jensen AL, Kjelgaard-Hansen M, et al. Study on biological variation of haemostatic parameters in clinically healthy dogs. Vet J. 2007;174:62-68.
42. Vilar P, Couto CG, Westendorf N, Iazbik C, Charske J, Marin L. Thromboelastographic tracings in retired racing greyhounds and in non-greyhound dogs. J Vet Intern Med. 2008;22:374-379.
43. Tripodi A, Cappellini MD, Chantarangkul V, et al. Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma. Haematologica. 2009;94:1520-1527.
44. Spiezia L, Radu C, Marchioro P, et al. Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients. Thromb Haemost. 2008;100:1106-1110.
45. Shibata J, Hasegawa J, Siemens HJ, et al. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood. 2003;101:4416-4422.
46. Iselin BM, Willimann PF, Seifert B, et al. Isolated reduction of haematocrit does not compromise in vitro blood coagulation. Br J Anaesth. 2001;87:246-249.
47. Kretschmer V, Daraktchiev A, Karger R. Does haemodilution produce a hypercoagulable state? Thromb Haemost. 2004;92:670-671.
48. Bauer NB, Eralp O, Moritz A. Effect of hemolysis on canine kaolin-activated thromboelastography values and ADVIA 2120 platelet activation indices. Vet Clin Pathol. 2010;39:180-189.
49. Dallap Schaer BL, Bentz AI, Boston RC, Palmer JE, Wilkins PA. Coagulation testing in critically ill neonatal foals: comparison between viscoelastic analysis and standard coagulation profiles [Abstract]. J Vet Emerg Crit Care (San Antonio). 2008;18:421.
50. Mendez J, Vilar P, Mudge M, Couto CG. Thromboelastography (TEG) for early detection of hemostatic abnormalities in horses with colic [Abstract]. J Vet Intern Med. 2008;22:816.
51. Mendez JL, Vilar P, Mudge MC, Couto CG. Thromboelastography (TEG): an innovative technique for early detection of hemostatic abnormalities in foals with septicemia [Abstract]. J Vet Intern Med. 2009;23:720.
52. Van Vliet KJ, Smit GL, Pieterse JJ, Schoonbee HJ, Van Vuren JH. Thrombelastographic diagnosis of blood coagulation in two freshwater fish species. Comp Biochem Physiol A Comp Physiol. 1985;82:19-21.
53. Van Vliet KJ, Smit GL, Pieterse JJ, Schoonbee HJ, Van Vuren JH. A thrombelastographic study of the effect of stress on the blood coagulation in Cyprinus carpio (Cyprinidae) and Oreochromis mossambicus (Cichlidae). Comp Biochem Physiol A Comp Physiol. 1985;82:23-27.
54. Raina S, Spillert CR, Greenstein SM, Lazaro EJ. Effect of surgery on tumor-induced accelerated coagulation in a rat carcinoma. J Surg Res. 1985;38:138-142.
55. Kaspareit J, Messow C, Edel J. Blood coagulation studies in guinea pigs (Cavia porcellus). Lab Anim. 1988;22:206-211.
56. Moalic P, Gruel Y, Foloppe P, Delahousse B, Leclerc MH, Leroy J. Hemostasis development in the lamb fetus and neonate. Am J Vet Res. 1989;50:59-63.
57. Heene D, Hoffmann-Fezer G, Muller-Berghaus G, Hoffmann R, Weiss E, Lasch HG. Gerinnungsstorungen bei akuter scheinepest [Coagulation disorders in acute hog cholera]. Beitr Pathol. 1971;144:259-271.
58. Hinaidy HK. Thrombelastogramn von mit Fasciola hepatica infizierten sehafen [The thromboelastogram of sheep infected with Fasciola hepatica]. Z Parasitenkd. 1968;31:12.
59. Kotschy M. Der einfluss von prothrombin- und fibrinogen-antisera auf das gerinnungssystem von rinderblut [Effect of prothrombin and fibrinogen antisera on the clotting system of bovine blood]. Folia Haematol Int Mag Klin Morphol Blutforsch. 1972;98:426-436.
60. Hardie EM, Vaden SL, Spaulding K, Malarkey DE. Splenic infarction in 16 dogs: a retrospective study. J Vet Intern Med. 1995;9:141-148.
61. Johnson LR, Lappin MR, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985-1995. J Vet Intern Med. 1999;13:338-345.
62. Van Winkle TJ, Bruce E. Thrombosis of the portal vein in eleven dogs. Vet Pathol. 1993;30:28-35.
63. Otto CM, Rieser TM, Brooks MB, Russell MW. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc. 2000;217:1500-1504.
64. Kristensen AT, Wiinberg B, Jessen LR, Adreasen E, Jensen AL. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med. 2008;22:140-147.
65. Sinnott VB, Otto CM. Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (2000-2008). J Vet Emerg Crit Care (San Antonio). 2009;19:484-488.
66. Fenty RK, DeLaforcade AM, Shaw SP, O'Toole TE. Identification of hypercoagulability in dogs with primary immune-mediated hemolytic anemia utilizing thromboelastography [Abstract]. J Vet Emerg Crit Care (San Antonio). 2008;18:411.
67. Kol A, Nelson RW, Borjesson DL. Dogs with hyperadrenocorticism are hypercoagulable and have prolonged PFA-100 closure times [Abstract]. Vet Clin Pathol. 2009;38(Suppl):E5.
68. Rose L, Bedrad C, Dunn M. Effect of prednisone administration on thrombelastographic parameters in healthy beagles [Abstract]. J Vet Intern Med. 2008;22:738.
69. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 2007;110:2339-2346.
70. Mohren M, Markmann I, Jentsch-Ullrich K, Koenigsmann M, Lutze G, Franke A. Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis. Br J Cancer. 2005;92:1349-1351.
71. Wada H, Sase T, Yamaguchi M. Hypercoagulant states in malignant lymphoma. Exp Oncol. 2005;27:179-185.
72. Winter PC. The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology. Hematol Oncol. 2006;24:126-133.
73. LaRue MJ, Murtaugh RJ. Pulmonary thromboembolism in dogs: 47 cases (1986-1987). J Am Vet Med Assoc. 1990;197:1368-1372.
74. Pusterla S, Previtali S, Marziali S, et al. Antiphospholipid antibodies in lymphoma: prevalence and clinical significance. Hematol J. 2004;5:341-346.
75. Van Zaane B, Nur E, Squizzato A, et al. Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab. 2009;94:2743-2750.
76. Dai Y, Lee A, Critchley LA, White PF. Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature. Anesth Analg. 2009;108:734-742.
77. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennet-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg. 2005;100:1576-1583.
78. Wilson D, Cooke EA, McNally MA, Wilson HK, Yeates A, Mollan RA. Changes in coagulability as measured by thrombelastography following surgery for proximal femoral fracture. Injury. 2001;32:765-770.
79. Bigge LA, Brown DJ, Penninck DG. Correlation between coagulation profile findings and bleeding complications after ultrasound-guided biopsies: 434 cases (1993-1996). J Am Anim Hosp Assoc. 2001;37:228-233.
80. Vaden SL, Levine JF, Lees GE, Groman RP, Graver GF, Forrester SD. Renal biopsy: a retrospective study of methods and complications in 283 dogs and 65 cats. J Vet Intern Med. 2005;19:794-801.
81. Prasad S, Lillicrap D, Labelle A, et al. Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A. Blood. 2008;111:672-679.
82. Othman M, Powell S, Chirinian Y, Hegadorn C, Hopman W, Lillicrap D. Thromboelastography reflects global hemostatic variation among severe haemophilia A dogs at rest and following acute exercise. Haemophilia. 2009;15:1126-1134.
83. Johansson PI, Stensballe J, Vindelov N, Perner A, Espersen K. Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul Fibrinolysis. 2010;21:168-174.
84. Feige K, Schwarzwald CC, Bombeli T. Comparison of unfractioned and low molecular weight heparin for prophylaxis of coagulopathies in 52 horses with colic: a randomised double-blind clinical trial. Equine Vet J. 2003;35:506-513.
85. Scott KC, Hansen BD, DeFrancesco TC. Coagulation effects of low molecular weight heparin compared with heparin in dogs considered to be at risk for clinically significant venous thrombosis. J Vet Emerg Crit Care (San Antonio). 2009;19:74-80.
86. Smith CE, Rozanski EA, Freeman LM, Brown DJ, Goodman JB, Rush JE. Use of low molecular weight heparin in cats: 57 cases (1999-2003). J Am Vet Med Assoc. 2004;225:1237-1241.
87. Jessen LR, Wiinberg B, Jensen AL, et al. In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time. Vet Clin Pathol. 2008;37:363-372.
88. Vargo CL, Taylor SM, Carr A, Jackson ML. The effect of a low molecular weight heparin on coagulation parameters in healthy cats. Can J Vet Res. 2009;73:132-136.
89. Van PY, Cho SD, Underwood SJ, Morris MS, Watters JM, Schreiber MA. Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients. J Trauma. 2009;66:1509-1515; discussion 1515-1507.
90. Brooks MB. von Willebrand disease. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology. 5th ed. Ames, IA: Blackwell Publishing; 2000:509-515.
91. Boudreaux MK. Characteristics, diagnosis, and treatment of inherited platelet disorders in mammals. J Am Vet Med Assoc. 2008;233:1251-1259, 1190.
92. Boudreaux MK. Acquired platelet dysfunction. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology. 5th ed. Ames, IA: Blackwell Publishing; 2000:496-500.
93. Baek SJ, McEntee MF, Legendre AM. Review paper: cancer chemopreventive compounds and canine cancer. Vet Pathol. 2009;46:576-588.
94. Papich MG. An update on nonsteroidal anti-inflammatory drugs (NSAIDs) in small animals. Vet Clin North Am Small Anim Pract. 2008;38:1243-1266, vi.
95. Mathews KA. Pain management for the pregnant, lactating, and neonatal to pediatric cat and dog. Vet Clin North Am Small Anim Pract. 2008;38:1291-1308, vi-vii.
96. Goodman L, Coles TB, Budsberg S. Leukotriene inhibition in small animal medicine. J Vet Pharmacol Ther. 2008;31:387-398.
97. Lascelles BD, Court MH, Hardie EM, Robertson SA. Nonsteroidal anti-inflammatory drugs in cats: a review. Vet Anaesth Analg. 2007;34:228-250.
98. Goodrich LR, Nixon AJ. Medical treatment of osteoarthritis in the horse-a review. Vet J. 2006;171:51-69.
99. Lindahl TL, Ramstrom S. Methods for evaluation of platelet function. Transfus Apher Sci. 2009;41:121-125.
100. Collet JP, Montalescot G. Platelet function testing and implications for clinical practice. J Cardiovasc Pharmacol Ther. 2009;14:157-169.
101. Craft RM, Chavez JJ, Bresee SJ, Worthman DC, Cohen E, Carroll RC. A novel modification of the thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med. 2004;143:301-309.
102. Brooks MB, Randolph J, Warner K, Center S. Evaluation of platelet function screening tests to detect platelet procoagulant deficiency in dogs with Scott syndrome. Vet Clin Pathol. 2009;38:306-315.
103. Brainard BM, Meredith CP, Callan MB, et al. Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs. Am J Vet Res. 2007;68:251-257.
104. Brainard BM, Kleine SM, Budsberg SC. Utility of thromelastograph (TEG) plateletmapping for evaluation of clopidogrel in dogs [Abstract]. J Vet Intern Med. 2008;22:739.
105. Bochsen L, Nielsen AB, Steinbruchel DA, Johansson PI. Higher thrombelastograph platelet reactivity in cardiac surgery patients than in blood donors. Scand Cardiovasc J. 2007;41:321-324.
106. Scharbert G, Auer A, Kozek-Langenecker S. Evaluation of the platelet mapping assay on rotational thromboelastometry ROTEM. Platelets. 2009;20:125-130.